IMMUNOGENICITY OF AN ACELLULAR PERTUSSIS-VACCINE COMPOSED OF GENETICALLY INACTIVATED PERTUSSIS TOXIN COMBINED WITH FILAMENTOUS HEMAGGLUTININ AND PERTACTIN IN INFANTS AND CHILDREN

被引:20
作者
PODDA, A
DELUCA, EC
TITONE, L
CASADEI, AM
CASCIO, A
BARTALINI, M
VOLPINI, G
PEPPOLONI, S
MARSILI, I
NENCIONI, L
RAPPUOLI, R
机构
[1] BIOCINE SCLAVO RES & DEV VACCINES, VIA FIORENTINA 1, I-53100 SIENA, ITALY
[2] UNIV ROMA LA SAPIENZA, IST PUERICULTURA, I-00185 ROME, ITALY
[3] UNIV PALERMO, MALATTIE INFETT CLIN, I-90134 PALERMO, ITALY
关键词
D O I
10.1016/S0022-3476(05)81543-4
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
We studied the immunogenicity of an acellular pertussis vaccine composed of genetically detoxified pertussis toxin (PT-9K/129G), filamentous haemagglutinin, and a 69-kilodalton protein, pertactin, in 30 children aged 12 to 24 months and in 80 infants aged 2 to 4 months. A significant increase of the neutralizing titer and of the titers against pertussis toxin, filamentous hemagglutinin, and pertactin, as determined by enzyme-linked immunosorbent assay, was achieved after three doses of vaccine in all the children; a significant increase of these antibody titers was obtained in 100%, 96.1%, 93.5%, and 98.7% of the infants, respectively.
引用
收藏
页码:81 / 84
页数:4
相关论文
共 9 条
[1]  
EDWARDS KM, 1992, P AM PEDIATRIC SOC S
[2]  
ENGLUND JA, 1991, 31ST INT C ANT AG CH
[3]   INDUCTION OF A NOVEL MORPHOLOGICAL RESPONSE IN CHINESE-HAMSTER OVARY CELLS BY PERTUSSIS TOXIN [J].
HEWLETT, EL ;
SAUER, KT ;
MYERS, GA ;
COWELL, JL ;
GUERRANT, RL .
INFECTION AND IMMUNITY, 1983, 40 (03) :1198-1203
[4]   IMMUNOGENICITY AND SAFETY OF A PERTUSSIS-VACCINE COMPOSED OF PERTUSSIS TOXIN INACTIVATED BY HYDROGEN-PEROXIDE, IN 18-MONTH-OLD TO 23-MONTH-OLD CHILDREN [J].
KRANTZ, I ;
SEKURA, R ;
TROLLFORS, B ;
TARANGER, J ;
ZACKRISSON, G ;
LAGERGARD, T ;
SCHNEERSON, R ;
ROBBINS, J .
JOURNAL OF PEDIATRICS, 1990, 116 (04) :539-543
[5]  
MANCLARK CR, 1986, MANUAL CLIN LAB IMMU, P388
[6]   PROPERTIES OF PERTUSSIS TOXIN MUTANT PT-9K/129G AFTER FORMALDEHYDE TREATMENT [J].
NENCIONI, L ;
VOLPINI, G ;
PEPPOLONI, S ;
BUGNOLI, M ;
DEMAGISTRIS, T ;
MARSILI, I ;
RAPPUOLI, R .
INFECTION AND IMMUNITY, 1991, 59 (02) :625-630
[7]   ACELLULAR PERTUSSIS-VACCINE COMPOSED OF GENETICALLY INACTIVATED PERTUSSIS TOXIN - SAFETY AND IMMUNOGENICITY IN 12-MONTH-OLD TO 24-MONTH-OLD AND 2-MONTH-OLD TO 4-MONTH-OLD CHILDREN [J].
PODDA, A ;
DELUCA, EC ;
TITONE, L ;
CASADEI, AM ;
CASCIO, A ;
PEPPOLONI, S ;
VOLPINI, G ;
MARSILI, I ;
NENCIONI, L ;
RAPPUOLI, R .
JOURNAL OF PEDIATRICS, 1992, 120 (05) :680-685
[8]   METABOLIC, HUMORAL, AND CELLULAR-RESPONSES IN ADULT VOLUNTEERS IMMUNIZED WITH THE GENETICALLY INACTIVATED PERTUSSIS TOXIN MUTANT PT-9K/129G [J].
PODDA, A ;
NENCIONI, L ;
DEMAGISTRIS, MT ;
DITOMMASO, A ;
BOSSU, P ;
NUTI, S ;
PILERI, P ;
PEPPOLONI, S ;
BUGNOLI, M ;
RUGGIERO, P ;
MARSILI, I ;
DERRICO, A ;
TAGLIABUE, A ;
RAPPUOLI, R .
JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 172 (03) :861-868
[9]   PHASE-I CLINICAL-TRIAL OF AN ACELLULAR PERTUSSIS-VACCINE COMPOSED OF GENETICALLY DETOXIFIED PERTUSSIS TOXIN COMBINED WITH FHA AND 69-KDA [J].
PODDA, A ;
NENCIONI, L ;
MARSILI, I ;
PEPPOLONI, S ;
VOLPINI, G ;
DONATI, D ;
DITOMMASO, A ;
DEMAGISTRIS, MT ;
RAPPUOLI, R .
VACCINE, 1991, 9 (10) :741-745